Dario Health Corp DRIO

$6.46 +0.30 (4.87%)

Valuation

Market cap
60,365,000
Revenue TTM
$22,360,000
Net income TTM
$-41,710,000
PE ratio
0.00
Forward PE
—
Profit margin
-186.54%
Debt to equity
0.56

Trading

Volume
34,300
Avg volume
25,196
Day's range
$6.07 – $6.61
Shares out
9,800,000
Stochastic %K
38%
Beta
1.18
Analysts
Sell
Price target
$10.00

Price

Company profile

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around...

Show more

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Industry
Health Information Services
Sector
Healthcare
Website
https://www.dariohealth.com
Address
322 W. 57th Street, New York, United States

Latest news

No headlines yet.